This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Frank DeRosa, PhD
CTO & Global Head of Research, mRNA Center of Exce at Sanofi


Frank is currently serving as Chief Technology Officer and Global Head of Research for Sanofi’s mRNA Center of Excellence (CoE). Prior to joining the CoE, he was the Chief Technology Officer and co-founder of the mRNA Therapeutics (MRT) platform at Translate Bio, which was acquired by Sanofi in 2021. Previous roles include serving as Senior Director of Preclinical Research and Process Development for the mRNA Therapeutics platform at Shire as well as holding positions at Enzon Pharmaceuticals, Takasago International Corporation and the National Cancer Institute (NIH). He is a co-inventor on over 110 issued U.S. patents and more than 60 additional pending patent applications. In addition, he is a co-author on over 25 scientific publications.

Agenda Sessions

  • Chairman’s Remarks: mRNA Preclinical and Clinical Progress Outside of COVID/ID Vaccines: New mRNA Therapeutic Frontiers & Novel Disease Indications